MedPath

Enteral Feeding in Infants With Duct Dependant Lesions.

Not Applicable
Not yet recruiting
Conditions
Death
Growth
Necrotising Enterocolitis
Duct Dependent Lesions
Registration Number
NCT05117164
Lead Sponsor
Princess Anna Mazowiecka Hospital, Warsaw, Poland
Brief Summary

This is a multicenter randomised controlled trial to assess whether standardised enteral feeding in newborns with duct dependenty congenital heart disease decreases the risk of necrotising enterocolitis (NEC). The investigators plan to include a total 384 infants. The study will be carried out in three level III hospitals in Poland. The primary end will be NEC and/or death. Secondary end points include weight gain, hospital length of stay, time required to reach full feeding.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
384
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Proportion of deathup to two weeks life

Death rate.

Proportion of final diagnosis of necrotizing enterocolitis (NEC).up to two weeks life

Number of infants diagnosed with NEC.

Secondary Outcome Measures
NameTimeMethod
Final median value of Vasoactive supportwithin 4 weeks

per day.

Median change from baseline of protein intakewithin 4 weeks

grams/kg

Proportion of number of interrupted feedingsfinal value within 4 weeks

per day.

Proportion of final value of days required to reach full enteral feedingwithin 4 weeks

days

Median change from baseline of caloric intakewithin 4 weeks

kcal/kg/day

Proportion of final value of days on mechanical ventilationwithin 4 weeks

days

Proportion of final value of days required to regain birth weightwithin 4 weeks

grams

Median change from baseline of breastfeeding of > 50%within 12 months

per study arm

Proportion of culture proven late onset sepsis4 weeks

per group

growthNumber of infants with a significant median change from baseline within 12 months

centimeters per week.

Trial Locations

Locations (2)

Department of Neonatology and Neonatal Intensive Care Warsaw Medical University

🇵🇱

Warsaw, Poland

Princess Anna Mazowiecka Hospital

🇵🇱

Warsaw, Poland

Department of Neonatology and Neonatal Intensive Care Warsaw Medical University
🇵🇱Warsaw, Poland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.